Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane versus propofol for myocardial protection in coronary artery bypass surgery
2013-001304-11Phase 4Active
- Sponsor
- Fundación IMABIS
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sevoflurane and propofol in coronary arteriosclerosis (2 arms), sponsored by Fundación IMABIS. Primary endpoint: Myocardial damage and injury biomarkers. Started Aug 2013; status: active.
02
Drugs
sevofluranepropofol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2013-001304-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001304-11.